TABLE 1.
TCGA (N = 250) | IRCR (N = 90) | P‐value | |
---|---|---|---|
Gender | |||
Female | 92 (36.8%) | 41 (45.6%) | .15 |
Male | 158 (63.2%) | 49 (54.4%) | |
Age | 61.4 ± 12.6 | 54.7 ± 11.6 | .001 |
IDH1 (250 vs 90) | |||
MUTANT | 12 (4.8%) | 4 (4.4%) | 1.000 |
WT | 238 (95.2%) | 86 (95.6%) | |
Treatment (234 vs 88) | |||
Stupp regimen | 95 (40.6%) | 87 (98.9%) | 2.2e‐16 |
Radiation therapy | 228 (97.4%) | 88 (100%) | .1404 |
Chemotherapy | 162 (69.2%) | 87 (98.9%) | |
TMZ chemo | 154 (65.8%) | 87 (98.9%) | |
Stupp regimen completion | Unknown | 46 (52.3%) |
Student t‐test was used for continuous variables and fisher's exact test was used to compare the categorical variables. P‐values below .05 were set to be statistically significant.